Omvoh (mirikizumab-mrkz intravenous infusion) — Medica

Initial criteria

• age ≥ 18 years
• medication will be used as induction therapy
• Patient meets ONE of the following (i, ii, iii, or iv): i) Patient has tried or is currently taking a systemic corticosteroid, or corticosteroid is contraindicated; OR ii) Patient has tried one other conventional systemic therapy for Crohn’s disease (e.g., azathioprine, 6-mercaptopurine, or methotrexate), unless already tried at least one biologic other than the requested medication; OR iii) Patient has enterocutaneous (perianal or abdominal) or rectovaginal fistulas; OR iv) Patient had ileocolonic resection
• Prescribed by or in consultation with a gastroenterologist

Approval duration

3 months